GFAP and supranuclear palsy, progressive, 1: Furthermore, ratios of biofluid markers can also discriminate PSP from healthy controls with higher levels of Glial Fibrillary Acidic Protein (GFAP)/t-tau and NfL/t-tau in CSF and plasma and lower levels of GFAP/NfL in CSF.49